Intrinsic Value of S&P & Nasdaq Contact Us

Nuvalent, Inc. NUVL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$137.44
+30.9%

Stock Statistics — NUVL

Nuvalent, Inc. (NUVL) has a market capitalization of $7.69B and trades at $105.02. The 52-week range is 55.535-113.015.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -18, Earnings Per Share (EPS) of $-5.85.

The stock has a beta of 1.31, operates in the Healthcare sector.

Trading Data
Current Price$105.02
52-Week Range55.535-113.015
Volume415.52K
Avg Volume (30D)664.97K
Market Cap$7.69B
Beta (1Y)1.31
Company
IPO Date2021-07-29
Employees162
CEOJames R. Porter
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS6707031075
CUSIP670703107
Income (Latest Year)
EBITDA$-10.49M
Operating Income$-414.31M
Net Income$-425.38M
EPS$-5.85
EPS Diluted$-5.85
Shares Outstanding$72.69M
Balance Sheet (Latest Year)
Total Assets$1.41B
Current Assets$1.39B
Cash & ST Investments$1.37B
Total Liabilities$164.37M
Net Debt$-261.75M
Total Equity$1.25B
Valuation Ratios
P/E Ratio-18
P/B Ratio6.16
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message